首页 > 最新文献

Interventional Pain Medicine最新文献

英文 中文
Pain in osteoarthritis: Driven by intrinsic rather than extrinsic joint afferents and why this should impact treatment 骨关节炎的疼痛:由关节内在传入而非外在传入引起的疼痛以及影响治疗的原因
Pub Date : 2024-03-01 DOI: 10.1016/j.inpm.2023.100381
Marshall Devor

Pain in osteoarthritis (OA) results from erosion of joint cartilage, resulting in bone contacting bone without an intervening cushion. The periosteum, including its nociceptive innervation, ends at the border of the cartilage. No other innervated tissue is present between the denuded articular bone ends that could serve as a neuronal pathway to carry a bone-on-bone pain signal to the brain. The pain signaling pathway must therefore originate in afferent axons with electrogenic nociceptive sensory endings that reside within the bone itself, specifically in the opposing surfaces of epiphyseal subchondral bone. Selective ablation of this intrinsic nerve pathway, using any of a variety of approaches, is expected to permanently eliminate OA pain.

骨关节炎(OA)的疼痛源于关节软骨的侵蚀,导致骨与骨之间没有缓冲垫。骨膜(包括其痛觉神经)止于软骨边界。在变性的关节骨末端之间没有其他神经支配组织可以作为神经元通路,将骨与骨之间的疼痛信号传递到大脑。因此,疼痛信号通路必须起源于具有电源性痛觉末梢的传入轴突,这些末梢位于骨本身,特别是骺软骨下骨的对立面。使用各种方法选择性地消融这一内在神经通路,有望永久消除 OA 疼痛。
{"title":"Pain in osteoarthritis: Driven by intrinsic rather than extrinsic joint afferents and why this should impact treatment","authors":"Marshall Devor","doi":"10.1016/j.inpm.2023.100381","DOIUrl":"https://doi.org/10.1016/j.inpm.2023.100381","url":null,"abstract":"<div><p>Pain in osteoarthritis (OA) results from erosion of joint cartilage, resulting in bone contacting bone without an intervening cushion. The periosteum, including its nociceptive innervation, ends at the border of the cartilage. No other innervated tissue is present between the denuded articular bone ends that could serve as a neuronal pathway to carry a bone-on-bone pain signal to the brain. The pain signaling pathway must therefore originate in afferent axons with electrogenic nociceptive sensory endings that reside within the bone itself, specifically in the opposing surfaces of epiphyseal subchondral bone. Selective ablation of this intrinsic nerve pathway, using any of a variety of approaches, is expected to permanently eliminate OA pain.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100381"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594423002133/pdfft?md5=a3a63ad00559b7e5aa4ade0c37f3864a&pid=1-s2.0-S2772594423002133-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140190591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-fidelity 3D modelling of the lumbar dorsal rami 腰椎背嵴的高保真三维建模
Pub Date : 2024-03-01 DOI: 10.1016/j.inpm.2024.100401
John Tran , Emma Campisi , Alexandria Roa Agudelo , Anne MR. Agur , Eldon Loh

Objective

Lumbar medial branch denervation is commonly used to treat chronic facetogenic low back pain. Controversy exists regarding risk to adjacent neural structures. The objectives of this cadaveric study were to: (1) dissect, digitize, and model in 3D the branches of the first (L1) to fifth (L5) lumbar dorsal rami located near the junction of the transverse process and lateral neck of the superior articular process; and (2) quantify the minimal distance between the lateral/intermediate and medial branches at the anterior quarter and midpoint of the lateral neck of the superior articular process.

Design

Eighteen formalin-embalmed specimens were dissected, digitized and modeled in 3D. The high-fidelity 3D models were used to compare branching patterns and quantify the mean minimal distance between the lateral/intermediate and medial branches of the lumbar dorsal ramus at the anterior quarter and midpoint of the lateral neck of the superior articular process. A Two-way ANOVA was performed to determine if difference of mean distances was significant.

Results

There was variability in the branching pattern of the lumbar dorsal rami. In 46 cases (51.1%) the lumbar dorsal ramus divided into 2 branches, in 41 cases (45.6%) into 3, and in 3 cases (3.3%) 4. The mean minimal distance between the lateral/intermediate and medial branches was significantly greater at the midpoint (3.2 ± 2.5 mm) than the anterior quarter (1.2 ± 1.8 mm) of the lateral neck of superior articular process.

Conclusion

Minimal distance measurements between the branches of the lumbar dorsal rami at the anterior quarter and midpoint of the lateral neck of the superior articular process were computed. When placing the distal end of the needle tip at the anterior quarter of the lateral neck of the superior articular process, the smaller mean minimal distance between the branches suggests there is a greater risk for inadvertent denervation of the lateral/intermediate branches. Further anatomical and clinical investigations are required.

目的腰椎内侧支神经支配常用于治疗慢性面源性腰痛。关于邻近神经结构的风险存在争议。这项尸体研究的目的是(1)解剖、数字化第一(L1)至第五(L5)腰椎背侧韧带位于横突和上关节突外侧颈交界处附近的分支,并对其进行三维建模;以及(2)量化外侧/中间分支和内侧分支在上关节突外侧颈前四分之一处和中点处的最小距离。高保真三维模型用于比较分支模式,并量化腰椎背侧横突外侧/中间分支和内侧分支在上关节突外侧颈前四分之一和中点处的平均最小距离。结果腰椎背侧韧带的分支模式存在差异。46例(51.1%)患者的腰背韧带分为2个分支,41例(45.6%)分为3个分支,3例(3.3%)分为4个分支。 外侧/中间分支和内侧分支之间的平均最小距离在中点(3.2 ± 2.5 mm)明显大于前四分之一(1.结论计算了腰椎背韧带分支在上关节突外侧颈前四分之一处和中点处的最小距离。当将针尖远端置于上关节突外侧颈的前四分之一处时,各分支之间的平均最小距离较小,这表明不慎剥夺外侧/中间分支的风险较大。还需要进一步的解剖和临床研究。
{"title":"High-fidelity 3D modelling of the lumbar dorsal rami","authors":"John Tran ,&nbsp;Emma Campisi ,&nbsp;Alexandria Roa Agudelo ,&nbsp;Anne MR. Agur ,&nbsp;Eldon Loh","doi":"10.1016/j.inpm.2024.100401","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100401","url":null,"abstract":"<div><h3>Objective</h3><p>Lumbar medial branch denervation is commonly used to treat chronic facetogenic low back pain. Controversy exists regarding risk to adjacent neural structures. The objectives of this cadaveric study were to: (1) dissect, digitize, and model in 3D the branches of the first (L1) to fifth (L5) lumbar dorsal rami located near the junction of the transverse process and lateral neck of the superior articular process; and (2) quantify the minimal distance between the lateral/intermediate and medial branches at the anterior quarter and midpoint of the lateral neck of the superior articular process.</p></div><div><h3>Design</h3><p>Eighteen formalin-embalmed specimens were dissected, digitized and modeled in 3D. The high-fidelity 3D models were used to compare branching patterns and quantify the mean minimal distance between the lateral/intermediate and medial branches of the lumbar dorsal ramus at the anterior quarter and midpoint of the lateral neck of the superior articular process. A Two-way ANOVA was performed to determine if difference of mean distances was significant.</p></div><div><h3>Results</h3><p>There was variability in the branching pattern of the lumbar dorsal rami. In 46 cases (51.1%) the lumbar dorsal ramus divided into 2 branches, in 41 cases (45.6%) into 3, and in 3 cases (3.3%) 4. The mean minimal distance between the lateral/intermediate and medial branches was significantly greater at the midpoint (3.2 ± 2.5 mm) than the anterior quarter (1.2 ± 1.8 mm) of the lateral neck of superior articular process.</p></div><div><h3>Conclusion</h3><p>Minimal distance measurements between the branches of the lumbar dorsal rami at the anterior quarter and midpoint of the lateral neck of the superior articular process were computed. When placing the distal end of the needle tip at the anterior quarter of the lateral neck of the superior articular process, the smaller mean minimal distance between the branches suggests there is a greater risk for inadvertent denervation of the lateral/intermediate branches. Further anatomical and clinical investigations are required.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100401"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000219/pdfft?md5=ac2398ce3ed2251a79a4af1baaed29b7&pid=1-s2.0-S2772594424000219-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effectiveness of cervical transforaminal epidural steroid injections for the treatment of cervical radicular pain: A prospective cohort study reporting 12-month outcomes 颈椎经椎间孔硬膜外类固醇注射治疗颈椎根性疼痛的有效性:报告 12 个月疗效的前瞻性队列研究
Pub Date : 2024-03-01 DOI: 10.1016/j.inpm.2024.100400
Kelly Li , Annette A. Wang
{"title":"The effectiveness of cervical transforaminal epidural steroid injections for the treatment of cervical radicular pain: A prospective cohort study reporting 12-month outcomes","authors":"Kelly Li ,&nbsp;Annette A. Wang","doi":"10.1016/j.inpm.2024.100400","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100400","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100400"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000207/pdfft?md5=8b07a45cdcbd650113039dfe51e26ad8&pid=1-s2.0-S2772594424000207-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the clinical outcomes of lumbar transforaminal vs interlaminar epidural steroid injections in a registry cohort 在登记队列中比较腰椎经椎间孔注射与椎间孔硬膜外类固醇注射的临床疗效
Pub Date : 2024-02-25 DOI: 10.1016/j.inpm.2024.100396
R Sterling Haring , D.J. Kennedy , Kristin R. Archer , Valentine U. Chukwuma , Jakob T. Dovgan , Byron J. Schneider

Background

Transforaminal and interlaminar approaches are both common means of performing epidural steroid injection. Comparative effectiveness data on outcomes of these approaches is available but has yielded mixed results.

Objective

Compare the effect of transforaminal vs interlaminar delivery of epidural steroids on patient-reported pain severity.

Design

Retrospective Cohort Study.

Methods

A retrospective review of prospectively collected interventional spine procedure registry data between December 2011 and July 2017 from a single academic medical center. Those who received epidural steroid injections and had prospectively collected index pain data (11-point Numeric Rating Scale [NRS]) recorded in the patient's chart prior to the procedure and at a 3 month follow up appointment were included. The outcome of interest was ≥50% reduction in pain as measured using a NRS for back and/or leg pain. To evaluate true predictive odds of success, multivariable logistic regression modeling was used to determine the odds of achieving improved pain.

Results

Of the 73 patients included in the study, 61 (84%) reported radicular pain, 49 (67%) reported back pain, and eleven (15%) had symptoms consistent with claudication, pain characteristics were not mutually exclusive. Fifty-one (70%) underwent transforaminal epidural steroid injection, while 22 (30%) underwent interlaminar injection. When claudication and radicular pain groups were combined into a single “leg pain” category (n = 66), 26/46 (57% 95% CI 41–71%) patients undergoing transforaminal and 6/20 (30% 95% CI 12–54%) patients undergoing interlaminar injections achieved ≥50% leg pain reduction on NRS (p = 0.048). Transforaminal epidural steroid injections were associated with higher odds of ≥50% reduction in leg pain in both the unadjusted model (OR 3.2, p = 00.034) and after adjustment for presence of radicular pain on presentation and the type of steroid used (OR 3.6, p = 0.042).

Conclusion

In this clinical practice registry, patients treated with transforaminal epidural steroid injection were more likely to achieve ≥50% reduction in radicular or neurogenic/claudicatory leg pain compared to those treated with interlaminar epidural steroid injection.

背景经椎间孔注射和椎间孔注射都是硬膜外类固醇注射的常用方法。目的比较经椎间孔与椎间孔注射硬膜外类固醇对患者报告的疼痛严重程度的影响。方法回顾性审查一家学术医疗中心在 2011 年 12 月至 2017 年 7 月期间前瞻性收集的脊柱介入手术登记数据。研究纳入了接受硬膜外类固醇注射的患者,这些患者在术前和 3 个月随访时的病历中记录了前瞻性收集的指数疼痛数据(11 点数字评分量表 [NRS])。根据背部和/或腿部疼痛的 NRS 值,疼痛减轻的幅度应≥50%。为了评估成功的真实预测几率,我们使用了多变量逻辑回归模型来确定疼痛得到改善的几率。结果在纳入研究的 73 名患者中,61 人(84%)报告有根性疼痛,49 人(67%)报告有背痛,11 人(15%)有与跛行一致的症状,疼痛特征并不相互排斥。51人(70%)接受了经椎间孔硬膜外类固醇注射,22人(30%)接受了层间注射。当跛行和根性疼痛组合并为一个 "腿痛 "类别时(n = 66),26/46(57% 95% CI 41-71%)名接受经椎间孔硬膜外类固醇注射的患者和 6/20 (30% 95% CI 12-54%)名接受椎间孔注射的患者的腿痛在 NRS 上减轻了≥50%(p = 0.048)。在未经调整的模型中(OR 3.2,p = 00.034),以及在对出现根性疼痛和使用的类固醇类型进行调整后(OR 3.6,p = 0.042),经椎间孔硬膜外类固醇注射与腿痛减轻≥50%的几率更高相关。结论 在这项临床实践登记中,与接受层间硬膜外类固醇注射治疗的患者相比,接受经椎间孔硬膜外类固醇注射治疗的患者更有可能使根性或神经根性/跛行性腿部疼痛减轻≥50%。
{"title":"Comparing the clinical outcomes of lumbar transforaminal vs interlaminar epidural steroid injections in a registry cohort","authors":"R Sterling Haring ,&nbsp;D.J. Kennedy ,&nbsp;Kristin R. Archer ,&nbsp;Valentine U. Chukwuma ,&nbsp;Jakob T. Dovgan ,&nbsp;Byron J. Schneider","doi":"10.1016/j.inpm.2024.100396","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100396","url":null,"abstract":"<div><h3>Background</h3><p>Transforaminal and interlaminar approaches are both common means of performing epidural steroid injection. Comparative effectiveness data on outcomes of these approaches is available but has yielded mixed results.</p></div><div><h3>Objective</h3><p>Compare the effect of transforaminal vs interlaminar delivery of epidural steroids on patient-reported pain severity.</p></div><div><h3>Design</h3><p>Retrospective Cohort Study.</p></div><div><h3>Methods</h3><p>A retrospective review of prospectively collected interventional spine procedure registry data between December 2011 and July 2017 from a single academic medical center. Those who received epidural steroid injections and had prospectively collected index pain data (11-point Numeric Rating Scale [NRS]) recorded in the patient's chart prior to the procedure and at a 3 month follow up appointment were included. The outcome of interest was ≥50% reduction in pain as measured using a NRS for back and/or leg pain. To evaluate true predictive odds of success, multivariable logistic regression modeling was used to determine the odds of achieving improved pain.</p></div><div><h3>Results</h3><p>Of the 73 patients included in the study, 61 (84%) reported radicular pain, 49 (67%) reported back pain, and eleven (15%) had symptoms consistent with claudication, pain characteristics were not mutually exclusive. Fifty-one (70%) underwent transforaminal epidural steroid injection, while 22 (30%) underwent interlaminar injection. When claudication and radicular pain groups were combined into a single “leg pain” category (n = 66), 26/46 (57% 95% CI 41–71%) patients undergoing transforaminal and 6/20 (30% 95% CI 12–54%) patients undergoing interlaminar injections achieved ≥50% leg pain reduction on NRS (p = 0.048). Transforaminal epidural steroid injections were associated with higher odds of ≥50% reduction in leg pain in both the unadjusted model (OR 3.2, p = 00.034) and after adjustment for presence of radicular pain on presentation and the type of steroid used (OR 3.6, p = 0.042).</p></div><div><h3>Conclusion</h3><p>In this clinical practice registry, patients treated with transforaminal epidural steroid injection were more likely to achieve ≥50% reduction in radicular or neurogenic/claudicatory leg pain compared to those treated with interlaminar epidural steroid injection.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100396"},"PeriodicalIF":0.0,"publicationDate":"2024-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000165/pdfft?md5=f9f234b61781685803dff61a9050f0cd&pid=1-s2.0-S2772594424000165-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139945163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness comparison of genicular nerve ablation for knee osteoarthritic versus post-total knee arthroplasty pain 膝关节骨性关节炎与全膝关节置换术后疼痛的膝神经消融疗效比较
Pub Date : 2024-02-24 DOI: 10.1016/j.inpm.2024.100390
Weibin Shi , To-Nhu Vu , Thiru Annaswamy , Hong Wu , Bryan Moore , Nicole Hatchard , Chad Mears , Allen R. Kunselman

Background

Genicular nerve radiofrequency ablation (GNRFA) is a popular and effective procedure to treat arthritic knee pain. For refractory arthritic pain that fails conservative treatment, total knee arthroplasty (TKA) has been an excellent option. Unfortunately, 15–30% of people who undergo a TKA continue to experience pain and stiffness in the knee. The treatment options for post-TKA knee pain are limited. Pain providers have been trialing GNRFA on this pain condition. However, convincing evidence of its efficacy in treating post-TKA pain is still lacking.

Methods

This is a retrospective study of 73 patients who had undergone genicular nerve RFA, 46 (63.01%) with osteoarthritic pain, and 27 (36.99%) with post-TKA pain. We compared the outcomes (pain relief, function, and complications) between these two groups at 3 months and 6 months after RFA.

Results

Before RFA, there was no significant difference in initial pain and functional level between these two groups. After RFA, the two groups had comparable pain relief at 3 months (p = 0.68) and 6 months (p = 0.53), and similar functionality at 3 months (p = 0.36) and 6 months (p = 0.65).

The overall success rate (≥50% pain relief after RFA) was 80.82%, 95% CI: 70.34%–88.22% (osteoarthritic group 80.43%, 95% CI: 66.83%–89.35%, post-TKA 81.48%, 95% CI: 63.30%–91.82%, P = 0.91) at 3-month follow-up and 56.16%, 95% CI: 44.76%–66.95% (osteoarthritic group 56.52%, 95% CI: 42.25%–69.79%, post-TKA 55.56%, 95% CI: 37.31%–72.41%, P = 0.94) at 6-month follow-up.

There were no reported complications in either group.

Conclusions

Genicular Nerve Radiofrequency Ablation (GNRFA) holds the potential to be equally effective for both post-TKA knee pain and osteoarthritic knee pain.

背景膝关节神经射频消融术(GNRFA)是治疗膝关节炎疼痛的一种流行而有效的方法。对于保守治疗无效的难治性关节炎疼痛,全膝关节置换术(TKA)一直是一个很好的选择。遗憾的是,15%-30% 的人在接受全膝关节置换术后会继续感到膝关节疼痛和僵硬。治疗 TKA 术后膝关节疼痛的方法非常有限。疼痛治疗机构一直在试用 GNRFA 治疗这种疼痛。这是一项回顾性研究,研究对象是 73 位接受过膝神经 RFA 治疗的患者,其中 46 位(63.01%)患有骨关节炎疼痛,27 位(36.99%)患有 TKA 术后疼痛。我们比较了两组患者在 RFA 术后 3 个月和 6 个月的治疗效果(疼痛缓解、功能和并发症)。射频消融术后,两组患者在 3 个月(p = 0.68)和 6 个月(p = 0.53)时的疼痛缓解程度相当,在 3 个月(p = 0.36)和 6 个月(p = 0.65)时的功能相似。3个月随访时,总成功率(RFA后疼痛缓解≥50%)为80.82%,95% CI:70.34%-88.22%(骨关节炎组80.43%,95% CI:66.83%-89.35%,TKA后81.48%,95% CI:63.30%-91.82%,P = 0.骨关节炎组 56.52%,95% CI:42.25%-69.79%,TKA 后 55.56%,95% CI:37.31%-72.41%,P = 0.94)。结论膝关节神经射频消融术 (GNRFA) 有可能对 TKA 后膝关节疼痛和骨关节炎膝关节疼痛同样有效。
{"title":"Effectiveness comparison of genicular nerve ablation for knee osteoarthritic versus post-total knee arthroplasty pain","authors":"Weibin Shi ,&nbsp;To-Nhu Vu ,&nbsp;Thiru Annaswamy ,&nbsp;Hong Wu ,&nbsp;Bryan Moore ,&nbsp;Nicole Hatchard ,&nbsp;Chad Mears ,&nbsp;Allen R. Kunselman","doi":"10.1016/j.inpm.2024.100390","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100390","url":null,"abstract":"<div><h3>Background</h3><p>Genicular nerve radiofrequency ablation (GNRFA) is a popular and effective procedure to treat arthritic knee pain. For refractory arthritic pain that fails conservative treatment, total knee arthroplasty (TKA) has been an excellent option. Unfortunately, 15–30% of people who undergo a TKA continue to experience pain and stiffness in the knee. The treatment options for post-TKA knee pain are limited. Pain providers have been trialing GNRFA on this pain condition. However, convincing evidence of its efficacy in treating post-TKA pain is still lacking.</p></div><div><h3>Methods</h3><p>This is a retrospective study of 73 patients who had undergone genicular nerve RFA, 46 (63.01%) with osteoarthritic pain, and 27 (36.99%) with post-TKA pain. We compared the outcomes (pain relief, function, and complications) between these two groups at 3 months and 6 months after RFA.</p></div><div><h3>Results</h3><p>Before RFA, there was no significant difference in initial pain and functional level between these two groups. After RFA, the two groups had comparable pain relief at 3 months (p = 0.68) and 6 months (p = 0.53), and similar functionality at 3 months (p = 0.36) and 6 months (p = 0.65).</p><p>The overall success rate (≥50% pain relief after RFA) was 80.82%, 95% CI: 70.34%–88.22% (osteoarthritic group 80.43%, 95% CI: 66.83%–89.35%, post-TKA 81.48%, 95% CI: 63.30%–91.82%, P = 0.91) at 3-month follow-up and 56.16%, 95% CI: 44.76%–66.95% (osteoarthritic group 56.52%, 95% CI: 42.25%–69.79%, post-TKA 55.56%, 95% CI: 37.31%–72.41%, P = 0.94) at 6-month follow-up.</p><p>There were no reported complications in either group.</p></div><div><h3>Conclusions</h3><p>Genicular Nerve Radiofrequency Ablation (GNRFA) holds the potential to be equally effective for both post-TKA knee pain and osteoarthritic knee pain.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100390"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000086/pdfft?md5=1ba26cb996d02940c8fb247d35d52424&pid=1-s2.0-S2772594424000086-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139942224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of endoscopic decompression surgery for treatment of lumbar spinal stenosis 内窥镜减压手术治疗腰椎管狭窄症的疗效
Pub Date : 2024-02-17 DOI: 10.1016/j.inpm.2024.100391
Dharam Persaud-Sharma , Chamara Gunaratne , Jay Talati , Will Philips , Akib Sohel , Andrew Blake , Terrie Vasilopoulos , Sanjeev Kumar

Background

The overall aim of this study was to assess the effectiveness of endoscopic decompression for outcomes in patients with lumbar spinal stenosis (LSS).

Methods

We conducted a retrospective cohort, single-institution study of n = 139 patients from 2019 to 2022 who underwent endoscopic decompression for LSS. The primary outcome was improvement of Oswestry Disability Index (ODI) between baseline and 12-month follow-up.

Results

In the present sample (n = 139) the average age was 57.6 years (SD = 17.4, with even distribution of men (49%) vs. women (51%). In patients with LSS, lumbar disc herniation was the most common diagnosis in 49 patients followed by lumbar radiculopathy in 25 patients. Lumbar radicular pain was the 3rd most common diagnosis in 21 patients with all other diagnosis listed in Table S1. There was a significant improvement (i.e., decrease) in ODI following endoscopic decompression (mean change: −8.3, 95% CI: −9.4, −7.2, P < 0.001, Fig. 1). Prior lumbar spine surgery (P = 0.048), BMI (P = 0.053), and age (P = 0.022) were associated with changes in ODI. Nearly half (47%) of the sample had prior lumbar spine surgery. Those with prior lumbar spine surgery (−7.5, 95% CI: −8.3, −6.6) showed less improvement than those without prior lumbar spine surgery (−9.1, 95% CI: −10.9, −7.2, Fig. 2). For BMI, 23% had normal BMI while 24% were overweight and 53% were obese. Patients with normal BMI (−10.3, 95% CI: −13.4, −7.2) showed greater improvements compared to overweight (−7.9, 95% CI: −9.4, −6.4) and obese (−7.6, 95% CI: −9.0, −6.3, Fig. 3) patients. Patients under 40 years old (−10.2, 95% CI: −13.6, −6.8) showed greater improvements in ODI compared to those 40 years and older (−7.8, 95% CI: −8.6, −6.8, Fig. 4).

Conclusions

In patients with lumbar spinal stenosis, endoscopic decompression was associated with reduced disability. Patients with no prior lumbar spine surgery, normal BMI, and who were under 40 years old showed greater improvements.

背景本研究的总体目标是评估内窥镜减压术对腰椎管狭窄症(LSS)患者疗效的影响。方法我们对2019年至2022年期间接受内窥镜减压术治疗LSS的139名患者进行了一项回顾性队列、单一机构研究。主要结果是基线和 12 个月随访期间 Oswestry 失能指数(ODI)的改善情况。结果在本样本(n = 139)中,平均年龄为 57.6 岁(SD = 17.4),男性(49%)和女性(51%)分布均匀。在腰椎间盘突出症患者中,最常见的诊断是腰椎间盘突出症(49 人),其次是腰椎病(25 人)。腰椎痛是第三大常见诊断,有 21 名患者,其他诊断见表 S1。内窥镜减压术后,ODI 有明显改善(即下降)(平均变化:-8.3,95% CI:-9.4,-7.2,P < 0.001,图 1)。之前的腰椎手术(P = 0.048)、体重指数(BMI)(P = 0.053)和年龄(P = 0.022)与 ODI 的变化有关。近一半的样本(47%)曾接受过腰椎手术。与未接受过腰椎手术的样本(-9.1,95% CI:-10.9,-7.2,图 2)相比,接受过腰椎手术的样本(-7.5,95% CI:-8.3,-6.6)的改善幅度较小。在体重指数方面,23%的患者体重指数正常,24%超重,53%肥胖。与超重(-7.9,95% CI:-9.4,-6.4)和肥胖(-7.6,95% CI:-9.0,-6.3,图 3)患者相比,体重指数正常(-10.3,95% CI:-13.4,-7.2)患者的病情改善幅度更大。与 40 岁及以上患者(-7.8,95% CI:-8.6,-6.8,图 4)相比,40 岁以下患者(-10.2,95% CI:-13.6,-6.8)的 ODI 改善幅度更大。既往未接受过腰椎手术、体重指数正常且年龄在40岁以下的患者的病情改善程度更大。
{"title":"Efficacy of endoscopic decompression surgery for treatment of lumbar spinal stenosis","authors":"Dharam Persaud-Sharma ,&nbsp;Chamara Gunaratne ,&nbsp;Jay Talati ,&nbsp;Will Philips ,&nbsp;Akib Sohel ,&nbsp;Andrew Blake ,&nbsp;Terrie Vasilopoulos ,&nbsp;Sanjeev Kumar","doi":"10.1016/j.inpm.2024.100391","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100391","url":null,"abstract":"<div><h3>Background</h3><p>The overall aim of this study was to assess the effectiveness of endoscopic decompression for outcomes in patients with lumbar spinal stenosis (LSS).</p></div><div><h3>Methods</h3><p>We conducted a retrospective cohort, single-institution study of n = 139 patients from 2019 to 2022 who underwent endoscopic decompression for LSS. The primary outcome was improvement of Oswestry Disability Index (ODI) between baseline and 12-month follow-up.</p></div><div><h3>Results</h3><p>In the present sample (n = 139) the average age was 57.6 years (SD = 17.4, with even distribution of men (49%) vs. women (51%). In patients with LSS, lumbar disc herniation was the most common diagnosis in 49 patients followed by lumbar radiculopathy in 25 patients. Lumbar radicular pain was the 3rd most common diagnosis in 21 patients with all other diagnosis listed in Table S1. There was a significant improvement (i.e., decrease) in ODI following endoscopic decompression (mean change: −8.3, 95% CI: −9.4, −7.2, <em>P</em> &lt; 0.001, Fig. 1). Prior lumbar spine surgery (<em>P</em> = 0.048), BMI (<em>P</em> = 0.053), and age (<em>P</em> = 0.022) were associated with changes in ODI. Nearly half (47%) of the sample had prior lumbar spine surgery. Those with prior lumbar spine surgery (−7.5, 95% CI: −8.3, −6.6) showed less improvement than those without prior lumbar spine surgery (−9.1, 95% CI: −10.9, −7.2, Fig. 2). For BMI, 23% had normal BMI while 24% were overweight and 53% were obese. Patients with normal BMI (−10.3, 95% CI: −13.4, −7.2) showed greater improvements compared to overweight (−7.9, 95% CI: −9.4, −6.4) and obese (−7.6, 95% CI: −9.0, −6.3, Fig. 3) patients. Patients under 40 years old (−10.2, 95% CI: −13.6, −6.8) showed greater improvements in ODI compared to those 40 years and older (−7.8, 95% CI: −8.6, −6.8, Fig. 4).</p></div><div><h3>Conclusions</h3><p>In patients with lumbar spinal stenosis, endoscopic decompression was associated with reduced disability. Patients with no prior lumbar spine surgery, normal BMI, and who were under 40 years old showed greater improvements.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100391"},"PeriodicalIF":0.0,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000098/pdfft?md5=e5c1fe597f6675c092f0539d0265664c&pid=1-s2.0-S2772594424000098-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139749399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dorsal root ganglion stimulation provides significant functional improvement from acute debilitating Crohn's disease: A novel use 刺激背根神经节可显著改善急性克罗恩病的功能性衰弱:一种新用途
Pub Date : 2024-02-02 DOI: 10.1016/j.inpm.2024.100389
Harman Chopra , Melissa Jackels , Michael Suarez , Peter D. Vu , Mustafa Broachwala , Tariq AlFarra , Eellan Sivanesan

Crohn's disease is a chronic inflammatory bowel condition causing symptoms, notably pain, due to ongoing intestinal inflammation or complications like abscesses, strictures, and fistulas, which are common in IBD patients. Abdominal pain affects up to 60 % of IBD patients, irrespective of disease severity, prompting medical attention. Various medications like NSAIDs, antidepressants, antispasmodics, anticonvulsants, and opioids are used to manage pain, but they have limited effectiveness and potential side effects, even during remission. In this case, a 20-year-old Caucasian female college student [height 5′4″, weight 120lbs (54.4 kg)] with juvenile idiopathic arthritis and Crohn's disease experienced severe daily abdominal pain, negatively impacting her life. Despite a multimodal regimen, including gabapentin, nortriptyline, duloxetine, and acetaminophen, her pain persisted, significantly affecting her appetite, sleep, mood, activity level, and overall quality of life (QOL). To address this, dorsal root ganglion (DRG) stimulation was considered. The patient aimed for a 20 % pain reduction and improved QOL. Trial leads were placed along the T10 and T12 DRG, resulting in a 25 % pain reduction (8–6 out of 10) and substantial QOL improvement. She could eat, sleep without interruptions, walk longer distances, and be more active. The T12 lead was more effective than the T10, targeting upper abdomen stimulation. The patient and her mother were highly satisfied and opted for permanent implantation for the T11 and T12 DRG. While DRG stimulation was approved in 2016 for chronic pain, to our knowledge, this is the first reported case of its use in a patient with debilitating Crohn's disease.

克罗恩病是一种慢性肠道炎症,由于持续的肠道炎症或并发症(如脓肿、狭窄和瘘管)而引起症状,尤其是疼痛,这在 IBD 患者中很常见。多达 60% 的 IBD 患者会出现腹痛,无论病情严重程度如何,都需要及时就医。非甾体抗炎药(NSAIDs)、抗抑郁药、解痉药、抗惊厥药和阿片类药物等各种药物被用来控制疼痛,但这些药物的疗效有限,而且有潜在的副作用,即使在缓解期也是如此。在本病例中,一名患有幼年特发性关节炎和克罗恩病的 20 岁高加索裔女大学生(身高 5'4″,体重 120 磅(54.4 千克))每天都感到剧烈腹痛,给她的生活带来了负面影响。尽管采取了包括加巴喷丁、去甲替林、度洛西汀和对乙酰氨基酚在内的多模式疗法,她的疼痛仍然持续,严重影响了她的食欲、睡眠、情绪、活动水平和整体生活质量(QOL)。为解决这一问题,考虑对背根神经节(DRG)进行刺激。患者的目标是疼痛减轻 20%,生活质量得到改善。沿着 T10 和 T12 背根神经节放置了试验导线,结果疼痛减轻了 25%(8-6 分,满分为 10 分),生活质量大幅提高。她可以不受干扰地进食、睡觉、走更远的路,而且更加活跃。T12 导联针对上腹部的刺激比 T10 导联更有效。患者及其母亲非常满意,并选择永久植入 T11 和 T12 DRG。虽然 DRG 刺激于 2016 年获准用于治疗慢性疼痛,但据我们所知,这是首例将其用于克罗恩病致残患者的报道。
{"title":"Dorsal root ganglion stimulation provides significant functional improvement from acute debilitating Crohn's disease: A novel use","authors":"Harman Chopra ,&nbsp;Melissa Jackels ,&nbsp;Michael Suarez ,&nbsp;Peter D. Vu ,&nbsp;Mustafa Broachwala ,&nbsp;Tariq AlFarra ,&nbsp;Eellan Sivanesan","doi":"10.1016/j.inpm.2024.100389","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100389","url":null,"abstract":"<div><p>Crohn's disease is a chronic inflammatory bowel condition causing symptoms, notably pain, due to ongoing intestinal inflammation or complications like abscesses, strictures, and fistulas, which are common in IBD patients. Abdominal pain affects up to 60 % of IBD patients, irrespective of disease severity, prompting medical attention. Various medications like NSAIDs, antidepressants, antispasmodics, anticonvulsants, and opioids are used to manage pain, but they have limited effectiveness and potential side effects, even during remission. In this case, a 20-year-old Caucasian female college student [height 5′4″, weight 120lbs (54.4 kg)] with juvenile idiopathic arthritis and Crohn's disease experienced severe daily abdominal pain, negatively impacting her life. Despite a multimodal regimen, including gabapentin, nortriptyline, duloxetine, and acetaminophen, her pain persisted, significantly affecting her appetite, sleep, mood, activity level, and overall quality of life (QOL). To address this, dorsal root ganglion (DRG) stimulation was considered. The patient aimed for a 20 % pain reduction and improved QOL. Trial leads were placed along the T10 and T12 DRG, resulting in a 25 % pain reduction (8–6 out of 10) and substantial QOL improvement. She could eat, sleep without interruptions, walk longer distances, and be more active. The T12 lead was more effective than the T10, targeting upper abdomen stimulation. The patient and her mother were highly satisfied and opted for permanent implantation for the T11 and T12 DRG. While DRG stimulation was approved in 2016 for chronic pain, to our knowledge, this is the first reported case of its use in a patient with debilitating Crohn's disease.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100389"},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000074/pdfft?md5=0564ebd6fbfad332f1c110baf2076d2b&pid=1-s2.0-S2772594424000074-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sciatic-nerve radiofrequency ablation for phantom limb pain: A case report 坐骨神经射频消融术治疗幻肢痛:病例报告
Pub Date : 2024-01-26 DOI: 10.1016/j.inpm.2024.100388
Melissa Schwartz , Pranamya Suri , Scott Benkovic , Eric Muneio , Nikhil Gopal , Akhil Chhatre

Phantom and residual limb pain are commonly experienced by the majority of amputees, and are often difficult to treat not adequately relieved with medical treatment alone. While extensively studied, the pathophysiology of refractory pain is still unclear, with many proposed mechanisms under investigation (Wilkes et al., 2008). Limited existing literature suggests percutaneous interventions including radiofrequency ablation (RFA) may be promising treatment modalities for patients who have pain refractory to oral agents (Sperry et al., 2023). We present a patient with persistent phantom limb and cancer-associated acetabular pain following hip disarticulation who underwent sciatic-notch RFA for pain management.

大多数截肢者都会经历幻肢痛和残肢痛,而且往往难以治疗,仅靠药物治疗无法充分缓解。虽然对难治性疼痛进行了广泛的研究,但其病理生理学仍不清楚,许多拟议的机制仍在研究中(Wilkes 等人,2008 年)。有限的现有文献表明,包括射频消融术(RFA)在内的经皮介入治疗可能是口服药物难治性疼痛患者的理想治疗方式(Sperry 等人,2023 年)。我们介绍了一位在髋关节离断术后出现持续性幻肢和癌症相关髋臼疼痛的患者,她接受了坐骨神经切口射频消融术治疗疼痛。
{"title":"Sciatic-nerve radiofrequency ablation for phantom limb pain: A case report","authors":"Melissa Schwartz ,&nbsp;Pranamya Suri ,&nbsp;Scott Benkovic ,&nbsp;Eric Muneio ,&nbsp;Nikhil Gopal ,&nbsp;Akhil Chhatre","doi":"10.1016/j.inpm.2024.100388","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100388","url":null,"abstract":"<div><p>Phantom and residual limb pain are commonly experienced by the majority of amputees, and are often difficult to treat not adequately relieved with medical treatment alone. While extensively studied, the pathophysiology of refractory pain is still unclear, with many proposed mechanisms under investigation (Wilkes et al., 2008). Limited existing literature suggests percutaneous interventions including radiofrequency ablation (RFA) may be promising treatment modalities for patients who have pain refractory to oral agents (Sperry et al., 2023). We present a patient with persistent phantom limb and cancer-associated acetabular pain following hip disarticulation who underwent sciatic-notch RFA for pain management.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100388"},"PeriodicalIF":0.0,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000062/pdfft?md5=b8bcd1ce3e77904555bf60be6e1be75d&pid=1-s2.0-S2772594424000062-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139652972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluoroscopic OnabotulinumtoxinA injection for Bertolotti Syndrome in refractory back pain: A letter to the editor 荧光透视下注射奥那巴妥妥毒素A治疗难治性背痛的贝尔托洛蒂综合征:致编辑的信
Pub Date : 2024-01-25 DOI: 10.1016/j.inpm.2024.100386
Ragav Sharma, Nicholas C. Ketchum, Heather M. Curtiss
{"title":"Fluoroscopic OnabotulinumtoxinA injection for Bertolotti Syndrome in refractory back pain: A letter to the editor","authors":"Ragav Sharma,&nbsp;Nicholas C. Ketchum,&nbsp;Heather M. Curtiss","doi":"10.1016/j.inpm.2024.100386","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100386","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100386"},"PeriodicalIF":0.0,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000049/pdfft?md5=258f10893add996a7b46cc42a7752bcf&pid=1-s2.0-S2772594424000049-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139652973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FactFinders for patient safety: Delaying epidural steroid injections: Infection and safe platelet cutoff 患者安全实况调查:延迟硬膜外类固醇注射:感染和安全血小板截止值
Pub Date : 2024-01-23 DOI: 10.1016/j.inpm.2024.100383
Patricia Zheng , David Hao , George Christolias , Ben Marshall , Clark C. Smith , Shaan Sudhakaran , Jaymin Patel , Zachary L. McCormick , the International Pain & Spine Intervention Society's Patient Safety Committee

This series of FactFinders presents a brief summary of the evidence and outlines recommendations to improve our understanding and management of patients with potential contraindications to epidural steroid injections.

本系列 "实况调查 "简要介绍了相关证据,并概述了相关建议,以增进我们对硬膜外类固醇注射潜在禁忌症患者的了解和管理。
{"title":"FactFinders for patient safety: Delaying epidural steroid injections: Infection and safe platelet cutoff","authors":"Patricia Zheng ,&nbsp;David Hao ,&nbsp;George Christolias ,&nbsp;Ben Marshall ,&nbsp;Clark C. Smith ,&nbsp;Shaan Sudhakaran ,&nbsp;Jaymin Patel ,&nbsp;Zachary L. McCormick ,&nbsp;the International Pain & Spine Intervention Society's Patient Safety Committee","doi":"10.1016/j.inpm.2024.100383","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100383","url":null,"abstract":"<div><p>This series of FactFinders presents a brief summary of the evidence and outlines recommendations to improve our understanding and management of patients with potential contraindications to epidural steroid injections.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100383"},"PeriodicalIF":0.0,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000013/pdfft?md5=721cdad61889b9ddc02fe9a877b1a940&pid=1-s2.0-S2772594424000013-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139549564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interventional Pain Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1